Johnson & Johnson suspends COVID-19 vaccine sales forecasts

Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could bring in as much as $3.5 billion this year.

Related Keywords

United States , Washington , Americans , , Centers For Disease , Pfizer , Washington Times , Johnson , Disease Control , New Brunswick , New Jersey Based Johnson , Dow Jones Industrial Average , B Pfizer , B Moderna ,